Clinical

Clinical management

Is there a dose response in myopia control?

A dose-response is where an increasing amount of a medication or intervention is correlated with a better clinical outcome. When it comes to myopia control, we investigate the evidence for a dose-response with spectacle, contact lens, atropine and outdoor time interventions.

The Topcon MYAH – Q&A with Mario Teufl

In our Q&A interview format, we talk to Mario Teufl, optometrist from Austria, who explains how he uses the Topcon MYAH in his practice for myopia management – from axial length to topography to dry eye and more.

Model eyes in myopia management

You may have left the concept of a ‘model eye’ back in your student days – learn how understanding the ocular power components of the eye can be applied to clinical diagnosis and management decisions in childhood progressive myopia.

Optimizing safety in orthokeratology

Optimizing safety in orthokeratology is crucial for successful patient outcomes. Learn about compliance challenges in children wearing ortho-k and how to manage them, as well as the latest data on safety and rates of complications as reported from clinical studies.

Pupil myopia management

Pupils and myopia management: what we know and need to learn

What is the relationship between pupil size and myopia management? As the pupil controls the light input to the retina, does pupil size influence myopia risk or the response to myopia treatments? This review covers atropine’s influence on pupil size, the relationship with treatment zone size in orthokeratology, combination treatments and advice on normal outcomes.

The OCULUS Myopia Master in Action – Q&A with Max Aricochi

Our new Q&A format is designed to explore a particular clinical topic, intervention, product or research paper with an expert. Here, we explore the OCULUS Myopia Master with practical questions of how optometrist Max Aricochi uses it in his clinic in Austria. We also provide you some additional tips to help you put Max’s recommendations to use in your own practice.

Can we predict long-term efficacy from short-term outcomes?

Comparison of myopia control interventions shows that around half of the total efficacy is observed in the first 12 months. How can we use this knowledge to select and monitor the most suitable treatment for the individual child with myopia? Learn more here.

The latest from the IMI and what it means in practice

The International Myopia Institute released their Volume 1 of reports in 2019 and Volume 2 in 2021. Here, we explore the latest round of reports in 2021 and what they each mean for clinical practice.

When to start myopia control

When to start myopia management

Myopia is becoming more common, as knowledge on detection and management increase. When should you start myopia control? Here we present an overview of when you might start myopia management across the spectrum of patient presentations. Since every child and their family are unique, we also point you towards more information for each situation.